Trial · NCT01700530
Exercise, Statins, and the Metabolic Syndrome
NCT01700530, Not applicable, Completed, University of Kansas Medical Center; results first posted 2016-02-05
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Exercise, Statins, and the Metabolic Syndrome. Trials, record NCT01700530. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01700530
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Exercise, Statins, and the Metabolic Syndrome
- NCT number
- NCT01700530
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 121 participants, actual
- Lead sponsor
- University of Kansas Medical Center
- Conditions
- Metabolic Syndrome, Obese, Sedentary
- Interventions
- Statin, Exercise only, Statins + Exercise
- First posted
- 2012-10-04
- Last updated
- 2016-02-05
- Results first posted
- 2016-02-05
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | % Change in VO2max (Fitness) | Change from Baseline to 12 weeks | % change in fitness between baseline and after 12 weeks of treatment will be assessed by VO2max |
| Secondary | Skeletal Muscle Mitochondrial Content (Citrate Synthase Enzyme Activity) | 12 weeks | % change in skeletal muscle mitochondrial content (measured by citrate synthase enzyme activity) from pre to post intervention |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | % Change in VO2max (Fitness) | Change from Baseline to 12 weeks | Statins blocked exercise induced change in fitness | percentage change of VO2max | MEAN |
| SECONDARY | Skeletal Muscle Mitochondrial Content (Citrate Synthase Enzyme Activity) | 12 weeks | percent change | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| % Change in VO2max (Fitness) | Statin | 0 | Standard Deviation 6 | percentage change of VO2max | |
| % Change in VO2max (Fitness) | Exercise Only | 10 | Standard Deviation 5 | percentage change of VO2max | |
| % Change in VO2max (Fitness) | Statins + Exercise | 1.5 | Standard Deviation 6 | percentage change of VO2max | |
| Skeletal Muscle Mitochondrial Content (Citrate Synthase Enzyme Activity) | Statin | 0 | Standard Error 10 | percent change | |
| Skeletal Muscle Mitochondrial Content (Citrate Synthase Enzyme Activity) | Exercise Only | 13 | Standard Error 7 | percent change | |
| Skeletal Muscle Mitochondrial Content (Citrate Synthase Enzyme Activity) | Statins + Exercise | -4.5 | Standard Error 8 | percent change |
Source ClinicalTrials.gov
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Statin | 9 | |
| Overall Study | STARTED | Exercise Only | 21 | |
| Overall Study | STARTED | Statins + Exercise | 20 | |
| Overall Study | COMPLETED | Statin | 9 | |
| Overall Study | COMPLETED | Exercise Only | 18 | |
| Overall Study | COMPLETED | Statins + Exercise | 19 | |
| Overall Study | NOT COMPLETED | Statin | 0 | |
| Overall Study | NOT COMPLETED | Exercise Only | 3 | |
| Overall Study | NOT COMPLETED | Statins + Exercise | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Statin | ||
| Total, all-cause mortality | Exercise Only | ||
| Total, all-cause mortality | Statins + Exercise | ||
| Total, other adverse events | Statin | 0 | 9 |
| Total, other adverse events | Exercise Only | 0 | 21 |
| Total, other adverse events | Statins + Exercise | 0 | 20 |
| Total, serious adverse events | Statin | 0 | 9 |
| Total, serious adverse events | Exercise Only | 0 | 21 |
| Total, serious adverse events | Statins + Exercise | 0 | 20 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 23583255 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01700530
GET https://conductscience.org/api/trials/v1/NCT01700530/registered